DOCUMENT RESOURCES FOR EVERYONE
Documents tagged
Documents Tyrosinemia

TyrosinemiaTyrosinemia Description Tyrosinemia is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine, a building

Documents Tyrosinemia, type 1

Genetic Fact Sheets for Parents Amino Acid Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial,

Documents TYPE II TYROSINEMIA

WHAT IS TYPE II TYROSINEMIA? Type II tyrosinemia is an inborn error of tyrosine metabolism caused by a deficient activity of the enzyme tyrosine aminotransferase (TAT). As

Documents The Management of Tyrosinemia

The Management of Tyrosinemia ABSTRACT Tyrosinemia is a rare autosomal recessive genetic metabolic disorder, which occurs due to the error of metabolism that affects the

Documents Tyrosinemias: Biochemistry and Clinical Laboratory Investigation

Laboratory Statistics and Quality ControlClinical Chemistry Fellow University of Virginia School of Medicine DOI:10.15428/CCTC.2018.292755 2 Overview tyrosine metabolism

Documents New Parents Guide to Tyrosinemia Type 1

New_Parents_Guide_to_Tyro.FH10 " # 2 52D 56 < >&6 7; ! 5 !2"7; ! 2$ 3@ & * & # ? ? & " '

Documents Richner-Hanhart Syndrome (Tyrosinemia Type II)

To the Editor: Richner-Hanhart syndrome, also known as tyrosinemia type II or oculocutaneous tyrosinemia, is a rare autosomal- recessive, childhood-onset, metabolic hereditary

Documents Tyrosinemia Type 1

bk6_Hereditary Ataxia_aNORD Guides for Physicians #1 Th e N at io n al O rg an iz at io n f o r R ar e D is o rd er s This booklet is the first in a series of free publications

Documents Impaired Cognitive Functioning in Patients with Tyrosinemia Type I Receiving Nitisinone

Impaired Cognitive Functioning in Patients with Tyrosinemia Type I Receiving NitisinoneUniversity of Groningen Impaired Cognitive Functioning in Patients with Tyrosinemia

Documents Hereditary tyrosinemia type I–associated mutations in fumarylacetoacetate hydrolase reduce the...

Hereditary tyrosinemia type I–associated mutations in fumarylacetoacetate hydrolase reduce the enzyme stability and increase its aggregation rateHereditary tyrosinemia